| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A natural history study of paediatric non-alcoholic fatty liver disease over 10 years
|
Draijer, Laura
|
|
|
5 |
5 |
p.
|
artikel
|
| 2 |
Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1
|
Gest, Caroline
|
|
|
5 |
5 |
p.
|
artikel
|
| 3 |
Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults
|
Zhang, Xinyuan
|
|
|
5 |
5 |
p.
|
artikel
|
| 4 |
Circulating indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH
|
Moore, Mary Patricia
|
|
|
5 |
5 |
p.
|
artikel
|
| 5 |
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
|
Simão, André Lopes
|
|
|
5 |
5 |
p.
|
artikel
|
| 6 |
Contents
|
|
|
|
5 |
5 |
p.
|
artikel
|
| 7 |
Copyright and information
|
|
|
|
5 |
5 |
p.
|
artikel
|
| 8 |
Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis
|
Simbrunner, Benedikt
|
|
|
5 |
5 |
p.
|
artikel
|
| 9 |
Editorial Board page
|
|
|
|
5 |
5 |
p.
|
artikel
|
| 10 |
Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials
|
Fulgenzi, Claudia Angela Maria
|
|
|
5 |
5 |
p.
|
artikel
|
| 11 |
Hepatocyte mARC1 promotes fatty liver disease
|
Lewis, Lara C.
|
|
|
5 |
5 |
p.
|
artikel
|
| 12 |
Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
|
Seidensticker, Max
|
|
|
5 |
5 |
p.
|
artikel
|
| 13 |
Infection prevention and control programme and COVID-19 measures: Effects on hospital-acquired infections in patients with cirrhosis
|
Di Cola, Simone
|
|
|
5 |
5 |
p.
|
artikel
|
| 14 |
Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation
|
Pompili, Enrico
|
|
|
5 |
5 |
p.
|
artikel
|
| 15 |
Pathological bile acid concentrations in chronic cholestasis cause adipose mitochondrial defects
|
Zhou, Weinan
|
|
|
5 |
5 |
p.
|
artikel
|
| 16 |
Reply to: “Does ammonia really disrupt brain oxygen homeostasis?”
|
Hosford, Patrick S.
|
|
|
5 |
5 |
p.
|
artikel
|
| 17 |
Rescue of infant progressive familial intrahepatic cholestasis type 3 mice by repeated dosing of AAV gene therapy
|
Weber, Nicholas D.
|
|
|
5 |
5 |
p.
|
artikel
|
| 18 |
TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling
|
Su, Wantong
|
|
|
5 |
5 |
p.
|
artikel
|
Tijdschrift beschrijving